Patent details

EP3119384 Title: TREATMENT OF INTRAHEPATIC CHOLESTATIC DISEASES

Basic Information

Publication number:
EP3119384
PCT Application Number:
US2015021502
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157141326
PCT Publication Number:
WO2015143178
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF INTRAHEPATIC CHOLESTATIC DISEASES
French Title of Invention:
TRAITEMENT DE MALADIES CHOLESTATIQUES INTRAHÉPATIQUES
German Title of Invention:
BEHANDLUNG VON INTRAHEPATISCHEN CHOLESTATISCHEN ERKRANKUNGEN
SPC Number:
LUC50017

Dates

Filing date:
19/03/2015
Grant date:
12/09/2018
EP Publication Date:
25/01/2017
PCT Publication Date:
24/09/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/09/2018
EP B1 Publication Date:
12/09/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/07/2025
 
 

Name:
CymaBay Therapeutics, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

History of Owners

From:
05/09/2018
To:
30/07/2025

Name:
CymaBay Therapeutics, Inc.
Address:
7999 Gateway Boulevard, Suite 130, Newark, CA 94560, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
31/10/2018
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MCWHERTER, Charles, A.
Address:
United States (US)

2

Name:
BOUDES, Pol
Address:
United States (US)

Priority

Priority Number:
201461968037 P
Priority Date:
20/03/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/09; A61K 31/192; A61P 1/16;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2025/10
Publication date:
05/09/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201837
Publication date:
12/09/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000280A
Date Registered:
30/07/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
changement d'adresse
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
CymaBay Therapeutics, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/03/2026
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
30/07/2025 Request For Change 1
07/08/2025 Outgoing Correspondence 1
19/11/2018 Outgoing Correspondence 1
31/10/2018 Power Of Attorney 1